Document is current
Any future updates will be listed below
-
Authors
Barisione, Emanuela
Boutros, Andrea http://orcid.org/0000-0002-5336-5578
Mora, Marco
Spagnolo, Francesco http://orcid.org/0000-0003-3287-1225
Tanda, Enrica Teresa
Genova, Carlo http://orcid.org/0000-0003-3690-8582
Tagliabue, Elena http://orcid.org/0000-0002-9200-197X
- License Information
-
More Information
Article History
Received: 17 November 2023
Accepted: 9 February 2024
First Online: 24 February 2024
Declarations
:
: Not applicable: Ethical approval for this case report was not requested. The presented case involves a retrospective analysis of clinical data and medical interventions performed as part of routine patient care. No experimental interventions or additional procedures beyond standard medical practice were conducted. The patient’s privacy and confidentiality have been strictly maintained in accordance with ethical guidelines. As such, formal ethical approval was deemed unnecessary for this retrospective case report. We are committed to adhering to ethical standards in medical research and patient care.
: Written informed consent were obtained from the patient for publication of this case report.
: ETT reported Honoraria for Bristol Myers Squibb; MSD; Pierre Fabre. FS reported Payment or honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events: Novartis, MSD, BMS, Pierre Fabre, Merck, Sanofi, Sun Pharma, IGEA, Philogen. Consulting fees: Novartis, MSD, Sun Pharma, Pierre Fabre, Philogen. All the other authors declare that they have no competing interests. CG reported Honoraria for speaker activity or advisory boards from Astra Zeneca, Bristol-Myers-Squibb, Eli Lilly, Merck-Sharp-Dohme, Novartis, Roche, Sanofi, Takeda.
